News

Pharmabiz10h
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...
Fierce Pharma1d
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
pharmaphorum2d
There's good news for RSV jab firms at delayed ACIP meeting
The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...
BERNAMA1d
RSV: A Health Challenge For Malaysia's Aging Population
In a statement today, GlaxoSmithKline Malaysia (GSK) highlighted that RSV is a common and highly contagious virus that can lead to serious health complications, including lower respiratory tract ...
Single-dose vaccine demonstrates sustained efficacy against RSV-related lower respiratory tract disease in older adults
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
New Atlas4d
Over 60s get long-term protection against RSV from single shot
A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...
CIDRAP4d
RSV tied to higher risk of death in adults; severe RSV linked to prematurity in kids
New studies on respiratory syncytial virus (RSV) in both adults and young children show that infections are linked to a ...